Ticker
ERNACompany Name
ERNEXA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
6/30/2025 | $ -14.45M | -115.54% | $ 12.5M |
3/31/2025 | $ -14.42M | -111.72% | $ 12.91M |
12/31/2024 | $ -16.2M | -119.27% | $ 13.58M |
9/30/2024 | $ -17.34M | -31.24% | $ 55.48M |
6/30/2024 | $ -16.86M | -173.1% | $ 9.74M |
3/31/2024 | $ -18.22M | -143.32% | $ 12.71M |
12/31/2023 | $ -20.43M | -172.01% | $ 11.88M |
9/30/2023 | $ -21.05M | -338.37% | $ 6.22M |
6/30/2023 | $ -21.39M | -147.49% | $ 14.5M |
3/31/2023 | $ -21.59M | -144.53% | $ 14.94M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Market Cap
(=) FCF Yield
FCF Yield for ERNEXA THERAPEUTICS INC is calculated as follows: FCF [ $ -2.59M ] / Market Cap [ $ 5.81M ]
(=) FCF Yield [ -44.64% ]
Minimum
Sep 30, 2023
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.62% |
median | 3.25% |
std | 11.36% |